aTyr Pharma | LIFE - Operating Expenses


aTyr Pharma reported $85.61M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Ardelyx USD 120.12M 14.46M Dec/2025
aTyr Pharma USD 85.61M 58.67M Dec/2025
Biogen USD 1.88B 81.4M Sep/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.29M 1.51M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Curis USD 9.02M 23.01M Dec/2025
Galapagos EUR 120.26M 7.43M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Grifols EUR 1.99B 217.4M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
United Therapeutics USD 804.8M 5.79B Dec/2025
Xoma USD 22.84M 1.67M Sep/2024